Abzena's global facilities are hubs of innovation in pharmaceutical development, led by CIO Dave Williamson. Williamson's diverse background, from the US Army to biotechnology, informs his approach to bioconjugate and…
The pharmaceutical and biotech sectors exhibited resilience amid broad economic turmoil, largely unaffected by sweeping tariffs. Companies like Catalyst Pharmaceuticals and Veeva Systems experienced only minor stock declines, while Amgen…
The biotech and pharmaceutical sectors are undergoing significant layoffs, driving strategic shifts and financial recalibrations. Companies like Nkarta and ElevateBio are reducing workforces to focus on core innovations and cost-effective…
The biotech and pharmaceutical industries face significant layoffs due to shifting priorities, financial challenges, and strategic realignments. Major companies like Nkarta, ElevateBio, Alector, and others are reducing their workforce to…
The biotech and pharmaceutical industries face significant layoffs as companies like Nkarta and Alector realign strategies, aiming for operational efficiency and innovation. Major players, including Novartis, are restructuring to align…
The biotech and pharmaceutical industries are undergoing strategic realignments, leading to layoffs as companies refocus on core objectives. Nkarta and Atea Pharmaceuticals have significantly reduced their workforce, emphasizing key therapeutic…
Biotech and pharma companies are undergoing significant workforce reductions to align strategic priorities with economic constraints. Key companies involved include Nkarta, ElevateBio, Atea Pharmaceuticals, Vaxart, and TC BioPharm. The focus…
Strategic layoffs in biotech and pharma define early 2025, driven by economic pressures and shifting priorities. Leaders like Nkarta and Alector implement significant workforce reductions, with Nkarta cutting 34%. Focus…